NEW YORK (GenomeWeb) – Pacific Biosciences said this week that Annoroad, a Beijing-based genomics firm, has purchased 10 of its Sequel instruments. Annoroad provides both clinical NGS testing and research sequencing services. PacBio said that Annoroad would use the Sequel instruments to contribute to the Annoroad Typical Chinese Genomes Database initiative and incorporate the technology into its service offerings.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.